Clinical Trial Update: KORTUC Phase II - Intra-tumoural Radiation Sensitizer in Patients With Locally Advanced/Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

Phase II study update of KORTUC, an intra-tumoural radiation sensitizer, in patients with locally advanced or recurrent breast cancer; the trial is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• KORTUC

Snippet

Sponsor: Institute of Cancer Research, United Kingdom | Conditions: Breast Cancer | Phase 2 | Status: RECRUITING